Raymond James & Associates’s Karyopharm Therapeutics KPTI Stock Holding History

Raymond James & Associates’s Portfolio KPTI Stock Details KPTI Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell
2018 Q1	$153K	Sell
2017 Q4	$189K	Buy
2017 Q3	$198K	Sell
2017 Q2	$345K	Buy
2017 Q1	$267K	Buy